financetom
Business
financetom
/
Business
/
Market Chatter: Sony Considers Passing Tariffs to Consumers, Weighs US Manufacturing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Sony Considers Passing Tariffs to Consumers, Weighs US Manufacturing
May 26, 2025 7:53 AM

12:03 PM EDT, 05/14/2025 (MT Newswires) -- Sony ( SONY ) is considering passing on tariff-related costs to consumers as part of efforts to offset an expected hit to earnings, technology news outlet The Verge reported Wednesday, citing CFO Lin Tao.

According to its fiscal 2025 forecast, Sony ( SONY ) estimates a 100 billion yen ($682.5 million) impact on operating income from proposed changes in US tariff policy, which are not yet finalized.

The company is also evaluating relocating some manufacturing to the US to reduce exposure, according to the news outlet.

Sony ( SONY ) continues to produce most of its PlayStation 5 hardware in China, leaving its gaming business especially vulnerable to import tariffs. In the year ended March, the company shipped 18.5 million PS5 units, down from 20.8 million a year earlier, bringing cumulative shipments to 77.7 million, the report added.

Shares of Sony ( SONY ) were up 1.5% in recent trading.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 24.90, Change: +0.36, Percent Change: +1.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Trump says China has to give US magnets or face 200% tariff
Trump says China has to give US magnets or face 200% tariff
Aug 25, 2025
(Reuters) -President Donald Trump told reporters on Monday that China has to give the United States magnets or we have to charge them 200% tariff or something amid a trade dispute between the two nations. China is increasingly sensitive about rare earths and its control over supply, adding several rare earth items and magnets to its export restriction list in...
AbbVie to Buy Experimental Depression Drug From Gilgamesh For up to $1.2 Billion
AbbVie to Buy Experimental Depression Drug From Gilgamesh For up to $1.2 Billion
Aug 25, 2025
01:31 PM EDT, 08/25/2025 (MT Newswires) -- AbbVie ( ABBV ) will acquire Gilgamesh Pharmaceuticals' investigational depression drug for up to $1.2 billion, expanding its psychiatry pipeline, the companies said Monday. The acquisition price for Gilgamesh' lead asset, bretisilocin, includes an upfront payment and milestones-based consideration. The transaction is subject to closing conditions. A phase 2a study of bretisilocin targeting...
FDA Flags Alarming Contamination At Novo Nordisk Indiana Plant, Including Cat Hair, Bacteria, And Foreign Particles
FDA Flags Alarming Contamination At Novo Nordisk Indiana Plant, Including Cat Hair, Bacteria, And Foreign Particles
Aug 25, 2025
The U.S. Food and Drug Administration (FDA) has identified repeated quality control failures, including foreign particle contamination, inadequate investigations, and insufficient corrective actions at the Novo Nordisk A/S operated facility in Bloomington, Indiana. In 2024, Novo Nordisk ( NVO ) acquired three fill-finish sites from Novo Holdings A/S for $11 billion. The acquisition was part of a larger deal where...
MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal
MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal
Aug 25, 2025
MannKind Corporation on Monday agreed to acquire scPharmaceuticals Inc. for a deal value of up to approximately $360 million, or $5.35 per share. The deal marks MannKind’s strategic expansion into cardiorenal medicine, establishing its cardiometabolic business alongside its orphan lung division. It is also made possible on the heels of MannKind’s $500 million strategic financing agreement with Blackstone. ScPharmaceuticals ( SCPH...
Copyright 2023-2026 - www.financetom.com All Rights Reserved